Karyopharm Therapeutics reported $47.67M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11895M 427M
Abbvie ABBV:US $ 13538M 1348M
Amgen AMGN:US $ 6238M 608M
AstraZeneca AZN:LN 11390M 621M
Astrazeneca AZN:US $ 11390M 621M
Biocryst Pharmaceuticals BCRX:US $ 49.92M 2.76M
Bristol Myers Squibb BMY:US $ 11648M 337M
Eli Lilly And LLY:US $ 7810M 189.9M
Enanta Pharmaceuticals ENTA:US $ 18.72M 8.93M
Epizyme EPZM:US $ 8.7M 2.89M
GlaxoSmithKline GSK:LN 9780M 253M
Johnson & Johnson JNJ:US $ 23426M 1378M
Karyopharm Therapeutics KPTI:US $ 47.67M 78.6M
Macrogenics MGNX:US $ 11.1M 3.05M
Merk MRK:US $ 15901M 2380M
Mirati Therapeutics MRTX:US $ 0.71M 0.41M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Novartis NOVN:VX SF 12814M 708M
Novartis NVS:US $ 12814M 708M
Pfizer PFE:US $ 25661M 2026M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Roche Holding ROG:VX 16.44B 474M
Sangamo Biosciences SGMO:US $ 28.23M 0.24M
Takeda 4502:JP Y 873289M 28005M
Tg Therapeutics TGTX:US $ 2.02M 0.3M
Ultragenyx Pharmaceutical RARE:US $ 79.94M 3.45M
Xencor XNCR:US $ 85.5M 68.52M
YTE INCY:US $ 733.24M 129.62M